NasdaqCM - Delayed Quote USD

Avalo Therapeutics, Inc. (AVTX)

10.21 -0.56 (-5.20%)
At close: June 7 at 4:00 PM EDT
10.15 -0.06 (-0.59%)
After hours: June 7 at 6:38 PM EDT

Insider Roster

Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.

Individual or EntityMost Recent TransactionDateShares Owned as of Transaction Date
ARMISTICE CAPITAL L.L.C. Beneficial Owner of more than 10% of a Class of Security Sale Jun 27, 2023 --
CAISSA CAPITAL MANAGEMENT LTD. Beneficial Owner of more than 10% of a Class of Security Purchase Jun 20, 2023 --
CALIAS PERICLES Officer Purchase Dec 10, 2019 52,462
COLA MICHAEL F Chief Executive Officer Purchase Jun 9, 2020 175,746
GREENWAY SCHOND LAMONT Chief Financial Officer Purchase Dec 10, 2021 3,883
HARRELL JAMES ARCHIE JR. Officer Purchase Dec 10, 2021 36,766
MILLER JOSEPH M Chief Financial Officer Purchase Dec 10, 2019 48,777
NEIL GARRY ARTHUR Chief Executive Officer Purchase Dec 9, 2022 9,220
SULLIVAN CHRISTOPHER RYAN Officer Purchase Dec 10, 2021 9,004
WILKINS H JEFFREY Officer Purchase Dec 10, 2021 33,373

Related Tickers